type 2 asthma
Respiratory · 2020–2020
1decision
1medicine
1carried consumer input
7individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| dupilumab Treatment of uncontrolled severe type 2 asthma (eosinophilic or allergic) in patients aged 12 years and older, both with and without oral corticosteroid… | Nov 2020 | Recommended with restriction | 7 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.